Citation Tools
Abstract
Posters October 5
PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER